EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory Board

Chaired by Dr. Carl Regillo, illustrious leader in retinal surgery
WATERTOWN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help…

Click here to view the original article.